Neuphoria Therapeutics earnings were -$9.6M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest NEUP earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$3.4M, up 869.7% from last quarter. For the last reported fiscal year 2026 ending Jun 30, 2026, NEUP reported annual earnings of -$9.3M, with 3,722.9% growth. The next NEUP earnings date is Nov 13, 2026.
Neuphoria Therapeutics Earnings Reports & History FAQ
What were Neuphoria Therapeutics's earnings last quarter?
Neuphoria Therapeutics (NASDAQ: NEUP) reported Q2 2026 earnings per share (EPS) of -$0.66, up 82.75% year over year. Total NEUP earnings for the quarter were -$3.39 million. In the same quarter last year, Neuphoria Therapeutics's earnings per share (EPS) was -$3.81.
The next NEUP earnings call is Nov 13, 2026. Add NEUP to your watchlist to be reminded of Neuphoria Therapeutics's next earnings date.
Is Neuphoria Therapeutics profitable or losing money?
As of the last Neuphoria Therapeutics earnings report, Neuphoria Therapeutics is currently losing money. Neuphoria Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$9.30 million, a 3,722.89% increase year over year.
What was NEUP's earnings growth in the past year?
As of Neuphoria Therapeutics's earnings date in Q4 2026, Neuphoria Therapeutics's earnings has grown year over year. NEUP earnings in the past year totalled -$9.58 million.
What are Neuphoria Therapeutics's earnings expectations?
The current EPS estimate for Neuphoria Therapeutics's earnings report in Nov 13, 2026 is -$0.56.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.